Into the Unknown

On March 17, 2015, I was diagnosed with early-stage breast cancer. Initially it was thought that I would need only a lumpectomy and radiation, but the biopsy changed everything.

The pathology report said that the tumor was HER2-positive and estrogen/progesterone positive. The HER2 protein makes the cancer more aggressive, so I would need, in addition to surgery and radiation, eighteen weeks of standard chemotherapy, a year of two other infused drugs and a hormone-blocking oral drug.

Still, the cancer was stage 1a with a decent prognosis, according to my oncologist, who said, “The good news here is that we have treatments for every part of your cancer. You are lucky.”

Into the Unknown Read More »